ClinicalTrials.gov record
Terminated Phase 2 Interventional

Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease

ClinicalTrials.gov ID: NCT00693004

Public ClinicalTrials.gov record NCT00693004. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 15, 2026, 2:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of PRX-03140 as Monotherapy in Subjects With Alzheimer's Disease

Study identification

NCT ID
NCT00693004
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Epix Pharmaceuticals, Inc.
Industry
Enrollment
236 participants

Conditions and interventions

Interventions

  • Donepezil Drug
  • PRX-03140 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2008
Primary completion
Dec 31, 2009
Completion
Not listed
Last update posted
Jul 29, 2009

Started 2008

United States locations

U.S. sites
33
U.S. states
16
U.S. cities
31
Facility City State ZIP Site status
Barrow Neurological Institute Phoenix Arizona 85013
PsyPharma Clinical Research, Inc. Phoenix Arizona 85050
Northwest NeuroSpecialists, PLLC Tucson Arizona 85741-3537
Synergy Clinical Research Center National City California 91950
Pacific Neuroscience Medical Group Oxnard California 93030
California Neuroscience Research Medical Group, Inc. Sherman Oaks California 91403
Torrance Clinical Research Torrance California 90505
Bradenton Research Center Bradenton Florida 34205
Brain Matters Research Delray Beach Florida 33445
Clinical Neuroscience Solutions, Inc. Jacksonville Florida 32216
Compass Research Orlando Florida 32806
Berma Research Group Plantation Florida 33317
Meridien Research St. Petersburg Florida 33709
Stedman Clinical Trials Tampa Florida 33613
Roskamp Institute Tampa Florida 33617
Four Rivers Clinical Research Paducah Kentucky 42003
J. Gary Booker, MD, APMC Shreveport Louisiana 71104
Maine Neurology Scarborough Maine 04074
The ICPS Group Norwood Massachusetts 02062
Alzheimer's Research Corporation Paterson New Jersey 08759
Global Medical Institutes Princeton New Jersey 08540
Social Psychiatry Research Institute Brooklyn New York 11235
The Mount Sinai Medical Center New York New York 10029
Behavioral Medical Research of Staten Island Staten Island New York 10305
The Neurological Institute, P.A. Charlotte North Carolina 28204
MedArk Morgantown North Carolina 28655
Neurology and Neuroscience Center of Ohio Toledo Ohio 43623
Tulsa Clinical Research, LLC Tulsa Oklahoma 74104
Rhode Island Mood and Memory Research Institute East Providence Rhode Island 02914
Todd Swick, MD, PA Houston Texas 77063
The Memory Clinic Bennington Vermont 05201
The Glennan Center for Geriatrics & Gerontology, Eastern Virginia Medical School Norfolk Virginia 23507
The Center for Excellence in Aging and Geriatric Health Williamsburg Virginia 23185

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00693004, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 29, 2009 · Synced May 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00693004 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →